Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Nerve block showdown: which approach eases shoulder pain best?

NCT ID NCT06852781

Symptom relief Sponsor: Kanuni Sultan Suleyman Training and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested two different ultrasound-guided injection methods to block the suprascapular nerve in 100 adults with chronic shoulder pain. The goal was to see which approach provides better pain relief. Participants had pain lasting over 3 months that wasn't helped by standard treatments.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
suprascapular nerve block (local anesthetic and/or steroid injection)
What this could lead to
If successful, this could point to a better way to relieve chronic shoulder pain without surgery.
What could go wrong
This is a small, completed trial comparing two injection techniques, not a new drug or cure. Results may not apply to all shoulder pain types, and benefits may be temporary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

100 people

The number who actually took part.

Started

Jan 2025

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

\- Patients over the age of 18 who have pain at or above visual analog scale (VAS) 4 despite pharmacological agents and physical therapy (passive range of motion, strengthening exercises) for more than 3 months and who meet the inclusion criteria will be included in the study.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients over the age of 18 who have pain at or above visual analog scale (VAS) 4 despite pharmacological agents and physical therapy (passive range of motion, strengthening exercises) for more than 3 months and who meet the inclusion criteria will be included in the study. * Patients with complete data to be scanned in their files Exclusion Criteria: * Patients with known malignancy, * patients who had shoulder injections within the last 3 months, * patients who changed their medical analgesic treatment or underwent surgery during follow-up, * patients with previous shoulder surgery or deformity, * patients with inflammatory arthritis and fibromyalgia, * patients with known cervical disc herniation, * patients with pacemakers, pregnant women, * patients with chronic decompensated disease, * hemiplegic patients, * patients with major psychopathology, * patients allergic to medications used during the procedure, * patients with infection in the procedure area, * patients with bleeding disorders, and patients who did not agree to participate in the study were excluded from the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neuromodulation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neuromodulation Shoulder pain chronic Ultrasound guided

Contacts and locations

Locations

  • Kanuni Sultan Süleyman Training and Research Hospital

    Istanbul, Turkey, 34000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.